Can a ‘double standard’ in paediatric medicine provide a framework to restructure repressive medical cannabis policies?

By Rayyan Zafar an Honorary Research Assistant for Drug Science Can a ‘double standard’ in paediatric medicine provide a framework to restructure repressive medical cannabis policies? In 2019, a drug called Zolgensma came to market. This drug used a particularly innovative gene therapy technique to treat infants suffering with an extremely rare and catastrophic neuromuscular  …


Coming Out

By Dr Anna Ross, an Honorary Research Assistant for Drug Science A reflection on the article “Coming Out”: Stigma, reflexivity and the drug researchers drug use.   In 2015 I started a PhD in drug policy at the University of Edinburgh. It had been a long journey, and at the age of 34, with two  …


2020 - The Year Of The Mushroom

By Dr Hannah Thurgur an Honorary Research Assistant for Drug Science As we welcome in the new year, Drug Science reflects on the year of 2020 for psilocybin research and celebrates these achievements. Here we focus on the use of psilocybin-assisted therapy in three different conditions to reflect the breadth of research currently taking place  …


Society’s inconsistent moral judgements of potentially harmful activities

What do horse riding, motorsports, base jumping, mountain climbing, storm chasing, and drug use have in common? They are of all course all potentially dangerous activities pursued for a thrill, a rush, and often a great deal of enjoyment. But in our modern-day prohibitionist culture, one of those things is not seen as being like  …